Company: AIBT
Filing Date: 2025-07-03
Form Type: 253G2
Source: 0001096906-25-001087
Chunk: 40

Company: AIBOTICS, INC.
Filing Date: 2025-07-03
Form: 253G2
Chunk 40
---
 property related to its “Phill Robot” and “Milky Way” products. In consideration for the acquisition of the Assets, Aibotics will issue a new class of Preferred Stock (the “Preferred Stock”) with a face value of $2,000,000, convertible into shares of the Company’s Common Stock (the “Common Stock”). All shares of Preferred Stock and Common Stock issued in conjunction with the transaction will be “restricted securities,” as defined in Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”). The Company also entered into employment agreements that have revenue-based incentives connected to sales generated by the assets acquired. The incentives could result in the employees receiving up to $7,000,000 of the Preferred Stock over a three-year period. Government Regulation The Phill Robot and Milkyway are not subject to FDA regulation and are not marketed as medical devices. They are, however, subject to regulation that covers all consumer products. The Consumer Product Safety Commission (CPSC) regulates mechanical, electrical, and fire hazards in consumer robots. Therefore, our products must comply with 16 CFR Part 1200+: Electrical safety and mechanical risk standards. 29 Employees The Company’s only full-time employee is its CEO who is also the CEO of Ehave Inc., of which the Company is a majority owned subsidiary. LEGAL PROCEEDINGS From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors. MANAGEMENT The following table sets forth the names, ages and positions of our current board members and executive officers:

| Name              |     | Age |     | Position with the Company                                  |     | With the      
 Company Since |
| Ben Kaplan (1)    |     |  53 |     | President, Chief Executive and Financial Officer, Director |     | Since 2021    |
| Mark Croskery (1) |     |  50 |     | Director                                                   |     | Since 2021    |

The business address of our officers and directors is c/o Aibotics, Inc., 100 SE 2 ndSt., Suite 2000, Miami